Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Inflammatory Bowel Diseases

Free Subscription 22.10.2018 1 Aliment Pharmacol Ther 1 Am J Gastroenterol 1 Dig Dis Sci 3 Inflamm Bowel Dis 3 J Crohns Colitis 2 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Aliment Pharmacol Ther

1. ORFANOUDAKI E, Drygiannakis I, Koutroubakis IE
   Letter: is there a role for infliximab biosimilar in patients with inflammatory bowel disease with secondary loss of response to infliximab innovator?
   Aliment Pharmacol Ther. 2018;48:1037-1038.
   PubMed     Text format    
   
   

   
   Am J Gastroenterol

2. 
   Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
   Am J Gastroenterol. 2018 Oct 12. pii: 10.1038/s41395-018-0312.
   PubMed     Text format    
   
   

   
   Dig Dis Sci

3. CALDERA F, Misch EA, Saha S, Wald A, et al
   Immunosuppression Does Not Affect Antibody Concentrations to Measles, Mumps, and Rubella in Patients with Inflammatory Bowel Disease.
   Dig Dis Sci. 2018 Oct 13. pii: 10.1007/s10620-018-5321.
   PubMed     Text format     Abstract available
   
   

   
   Inflamm Bowel Dis

4. MUNIZ PEDROGO DA, Chen J, Hillmann B, Jeraldo P, et al
   An Increased Abundance of Clostridiaceae Characterizes Arthritis in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Cross-sectional Study.
   Inflamm Bowel Dis. 2018 Oct 12. pii: 5128781. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
5. DE JONG DC, Lo Wenberg M, Koumoutsos I, Ray S, et al
   Validation and Investigation of the Operating Characteristics of the Ulcerative Colitis Endoscopic Index of Severity.
   Inflamm Bowel Dis. 2018 Oct 17. pii: 5134157. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
6. POUILLON L, Baumann C, Rousseau H, Choukour M, et al
   Treatment Persistence of Infliximab Versus Adalimumab in Ulcerative Colitis: A 16-Year Single-Center Experience.
   Inflamm Bowel Dis. 2018 Oct 16. pii: 5133439. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   J Crohns Colitis

7. MAGRO F, Dias CC, Portela F, Miranda M, et al
   Development and validation of risk matrices concerning ulcerative colitis outcomes - Bayesian network analysis.
   J Crohns Colitis. 2018 Oct 17. pii: 5133622. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
8. LOREN V, Garcia-Jaraquemada A, Naves JE, Carmona X, et al
   ANP32E, a protein involved in steroid-refractoriness in ulcerative colitis, identified by a systems biology approach.
   J Crohns Colitis. 2018 Oct 17. pii: 5134087. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
9. AARESTRUP J, Jess T, Kobylecki CJ, Nordestgaard BG, et al
   Cardiovascular risk profile among patients with inflammatory bowel disease: a population-based study of >100,000 individuals.
   J Crohns Colitis. 2018 Oct 13. pii: 5128952. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Proc Natl Acad Sci U S A

10. LOPETUSO LR, De Salvo C, Pastorelli L, Rana N, et al
    IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair.
    Proc Natl Acad Sci U S A. 2018;115:E9362-E9370.
    PubMed     Text format     Abstract available
    
    
11. GARCIA-CARBONELL R, Wong J, Kim JY, Close LA, et al
    Elevated A20 promotes TNF-induced and RIPK1-dependent intestinal epithelial cell death.
    Proc Natl Acad Sci U S A. 2018;115:E9192-E9200.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: